Download App

Log in to access Online Inquiry
Company Overview More
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.
CEO: Melo, John G.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

AMRS Amyris
2.310-0.110-4.55%
Post Mkt Price
2.340+0.03+1.30%
YOY
Do not show
Hide blank lines
(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30
Assets
Current assets
Cash, cash equivalents and short term investments
100.17% 287.89M 1503.42% 483.46M 1503.42% 483.46M 200.12% 114.89M
-Cash and cash equivalents
100.17% 287.89M 1503.42% 483.46M 1503.42% 483.46M 200.12% 114.89M
Receivables
58.43% 58.68M -6.31% 48.16M -6.31% 48.16M 58.38% 52.34M
-Accounts receivable
62.9% 44.68M -4.93% 42.74M -4.93% 42.74M 64.7% 45.76M
-Taxes receivable
27.25% 1.3M 11.76% 1.19M 11.76% 1.19M -46.16% 1.07M
-Other receivables
47.85% 12.7M -21.45% 4.23M -21.45% 4.23M 67.82% 5.51M
Inventory
72.75% 82.3M 75.14% 75.07M 75.14% 75.07M 93.65% 72.06M
Prepaid assets
156.03% 34.44M 278.79% 25.14M 278.79% 25.14M 276.7% 23.04M
Restricted cash
-38.52% 174K -35.6% 199K -35.6% 199K -13.07% 286K
Current deferred assets
-- -- -- 0 -- 0 -2.88% 9.18M
Other current assets
56.3% 7.46M 32.98% 7.19M 32.98% 7.19M -7.85% 6.27M
Total current assets
86.71% 470.94M 336.13% 639.21M 336.13% 639.21M 111.88% 278.06M
Non current assets
Net PPE
265.21% 184.66M 112.44% 112.61M 112.44% 112.61M 46.13% 75.11M
-Gross PPE
113.1% 279.93M 48.83% 198.3M 48.83% 198.3M 18.08% 159.58M
-Accumulated depreciation
-17.91% -95.27M -6.8% -85.69M -6.8% -85.69M -0.87% -84.47M
Goodwill and other intangible assets
-- 192.1M -- 170.52M -- 170.52M -- 168.35M
-Goodwill
-- 136.01M -- 131.26M -- 131.26M -- 128.69M
-Other intangible assets
-- 56.09M -- 39.27M -- 39.27M -- 39.66M
Investments and advances
474.26% 19.7M 296.76% 9.44M 296.76% 9.44M -39.02% 2.47M
Non current accounts receivable
160.05% 22.57M 93.73% 16.74M 93.73% 16.74M 153.66% 13.01M
Non current deferred assets
-- -- -- 0 -- 0 -74.19% 3.06M
Non current prepaid assets
254.76% 447K 0.78% 129K 0.78% 129K 3.17% 130K
Other non current assets
269.6% 8.04M 161.71% 5.65M 161.71% 5.65M -1.26% 2.11M
Total non current assets
474.89% 427.51M 313.23% 315.09M 313.23% 315.09M 253.73% 264.24M
Total assets
175.1% 898.45M 328.29% 954.3M 328.29% 954.3M 163.33% 542.31M
Liabilities
Current liabilities
Payables
169.72% 120.82M 167.87% 111.7M 167.87% 111.7M 267.14% 113.47M
-accounts payable
99.96% 88.29M 94.09% 79.67M 94.09% 79.67M 165.66% 80.65M
-Total tax payable
92.96% 1.23M 50.61% 988K 50.61% 988K 64.91% 907K
-Other payable
-- 31.29M -- 31.05M -- 31.05M -- 31.92M
Current accrued expenses
13.6% 28.6M -5.78% 22.52M -5.78% 22.52M 10.16% 23.46M
Current provisions
38.03% 4.15M 9.7% 3.34M 9.7% 3.34M 29.5% 3.37M
Current debt and capital lease obligation
48.16% 95.82M 33.76% 116.15M 33.76% 116.15M 675.98% 313.22M
-Current debt
56.85% 87.69M 39.89% 108.32M 39.89% 108.32M 871.17% 305.25M
-Current capital lease obligation
-7.25% 8.13M -16.68% 7.83M -16.68% 7.83M -10.8% 7.97M
Current deferred liabilities
-74.79% 1.55M -43.38% 2.53M -43.38% 2.53M -21.31% 3.49M
Other current liabilities
362.79% 15.29M 335.57% 13.57M 335.57% 13.57M -24.08% 3.02M
Current liabilities
80.96% 266.22M 65.47% 269.81M 65.47% 269.81M 344.12% 460.03M
Non current liabilities
Long term debt and capital lease obligation
62.73% 709.12M 68.39% 328.95M 68.39% 328.95M -83.97% 24.88M
-Long term debt
57.17% 672.01M 66.5% 309.06M 66.5% 309.06M -88.04% 17.1M
-Long term capital lease obligation
352.15% 37.12M 104.38% 19.89M 104.38% 19.89M -36.6% 7.79M
Non current deferred liabilities
-- -- 0% 111K 0% 111K 0% 111K
Derivative product liabilities
-83.28% 5.25M -18.81% 7.06M -18.81% 7.06M 459.86% 21.47M
Preferred securities outside stock equity
-- -- -- -- -- -- -- 28.52M
Other non current liabilities
95.66% 43.74M 205.44% 69.16M 205.44% 69.16M 307.33% 89.15M
Total non current liabilities
54.84% 758.11M 78.69% 405.29M 78.69% 405.29M -9.37% 164.13M
Total liabilities
60.87% 1.02B 73.16% 675.09M 73.16% 675.09M 119.26% 624.15M
Shareholders'equity
Share capital
0.1% 5.03M 0.14% 5.03M 0.14% 5.03M 0.14% 5.03M
-common stock
0.1% 5.03M 0.14% 5.03M 0.14% 5.03M 0.14% 5.03M
-Preferred stock
-- 0 -- 0 -- 0 -- --
Retained earnings
-3.41% -2.46B -12.99% -2.36B -12.99% -2.36B -21.16% -2.4B
Paid-in capital
10.99% 2.34B 35.75% 2.66B 35.75% 2.66B 21.67% 2.36B
Gains losses not affecting retained earnings
24.14% -37.48M -11.39% -52.77M -11.39% -52.77M -5.31% -52.13M
Total stockholders'equity
51.35% -153.79M 246.34% 251.44M 246.34% 251.44M -1.23% -84.17M
Noncontrolling interests
367.24% 27.91M 481.67% 27.77M 481.67% 27.77M -47.42% 2.32M
Total equity
59.41% -125.88M 267.15% 279.21M 267.15% 279.21M -3.96% -81.85M
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
--Unqualified Opinion with Explanation----

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%